Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis

Phase 2 Terminated 14 enrolled Assistance Publique - Hôpitaux de Paris

RandomizedParallel-groupDouble-blindTreatment

Summary

Multicenter randomized double-blind study comparing the efficacy and safety of rituximab in combination with corticosteroids to corticosteroids plus placebo in the treatment of non-infectious active mixed cryoglobulinemia vasculitis.

Timeline

Start: 2015-07-17
Primary completion: 2018-05-31
Completion: 2018-05-31

Outcome

Outcome not reported

Stopped (Enrollment): “lack of recruitment”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rituximab	Monoclonal antibody	375 mg/m2	Intravenous
Background	Prednisone	Other / unclassified	—	—

Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis

Summary

Timeline

Outcome

Drugs

Indications